Shimadzu–Johns Hopkins Univ: mass spectrometry, 201005– collab develop glycoproteomics immuno-MS assays for prostate cancer blood tests

	Period	2010-05-24
	Partner, 1st	Shimadzu Scientific Instruments Inc. (SSI)
	Group	Shimadzu (Group)
	Partner, 2nd	Johns Hopkins Center for Biomarker Discovery
	Group	Johns Hopkins University
	Product	mass spectrometry (MS)

Shimadzu Scientific Instruments, Inc.. (5/24/10). "Press Release: Shimadzu to Introduce New Technologies at ASMS 2010 Conference". Columbia, MD.

Shimadzu Scientific Instruments will host new product showcases and poster presentations, as well as a hospitality suite and press conference, as part of its exhibition plans for the 58th ASMS Conference on Mass Spectrometry (May 23-27, Salt Palace Convention Center, Salt Lake City, Booth 86).

In addition to showcasing its full range of instruments, from MALDI and LCMS mass spectrometers to GCMS and a series of front-end LC systems, Shimadzu will highlight the following new products:

* AXIMA MegaTOFTM - An integrated MALDI solution from Shimadzu and CovalX for ultra high-mass applications that detects intact complexes up to 1.5 MDa.

* Nexera Ultra High-Performance Liquid Chromatograph - The new, modular Nexera meets all analysis requirements with no compromise in data integrity. It delivers the best performance, reliability and flexibility for any mass spectrometry environment.

* Nanotrap® Biomarker Discovery Platform - This platform gives researchers the ability to enrich, preserve and screen low-level biomarkers directly from complex biological samples.

* Component ID Solution - New software accelerates high-confidence component identification using the power of high mass accuracy and the simplicity of an open access workflow.

* Accelerating Structural ID with ACD MS Manger Software - A collaboration between ACD and Shimadzu brings chemical structure information closer to the LCMS-IT-TOF.

Additionally, Shimadzu and Johns Hopkins Center for Biomarker Discovery have partnered to develop new glycoproteomics technologies. The collaboration will focus on developing immuno-MS assays to identify prostate-specific glycoproteins and their glycosylation patterns toward improved blood tests for early stage prostate cancer.

Shimadzu will also present 37 posters in a variety of sessions, including Biomarker Discovery, Metabolemics, Glycoproteins, Proteomics, Small Molecule Analysis, Environmental Analysis and Natural Products. For more information, visit www.ssi.shimadzu.com/ASMS

About Shimadzu Scientific Instruments Inc.

Shimadzu Scientific Instruments is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $2 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. The Analytical Instruments division is one of the world's largest manufacturers of analytical instrumentation and environmental monitoring equipment. In 1975, SSI corporate headquarters was established in Columbia, Md., to provide analytical solutions to laboratories in North, Central and parts of South America. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit www.ssi.shimadzu.com for more information.

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Shimadzu–Johns Hopkins Univ: mass spectrometry, 201005– collab develop glycoproteomics immuno-MS assays for prostate cancer blood tests

Shimadzu Scientific Instruments, Inc.. (5/24/10). "Press Release: Shimadzu to Introduce New Technologies at ASMS 2010 Conference". Columbia, MD.

More documents for Shimadzu (Group)